What is the most common breast pathology? Learn more to attend the CME/CPD accredited #12Breastpath2023 in Dubai, UAE.
Since invasive ductal carcinoma is the most prevalent type of breast cancer, it is also known as invasive mammary carcinoma of no special type. The cells lining the ducts and lobules in the breast give rise to both invasive ductal carcinomas and invasive lobular carcinomas.
the breast cancer pathology:
Introduction:
Carcinomas are the most common type of breast cancer and are caused by epithelial components. Although these illnesses are frequently considered as a single disease, breast carcinomas are a varied set of lesions that vary in microscopic appearance and biologic function.
Either ductal (also known as intraductal carcinoma) or lobular carcinomas are in situ breast tumors. This distinction is made more so on the basis of the lesions' cytologic characteristics and development pattern than on where in the mammary ductal-lobular system they are anatomically located.
The estimated percentages come from a recent population-based series of 135,157 women with breast cancer reported to the Surveillance, Epidemiology and End Results (SEER) database of the National Cancer Institute between 1992 and 2001. The invasive breast carcinomas consist of various histologic subtypes.
Mammary cancer:
The leading cause of mortality for women between the ages of 40 and 59 in the US is breast cancer, which is also the second most frequent cancer among women. Invasive breast cancer will affect 1 in 8 women in the US [12%] at some point in their lives [19]. The most recent estimates for breast cancer in the US from the American Cancer Society are for 2012:
• There will be about 226,870 new instances of invasive breast cancer in women.
• There will be 63,300 new instances of carcinoma in situ (CIS) identified. (CIS is non-invasive and is the earliest form of breast cancer).
• Breast cancer will claim the lives of about 39,510 women [20].
Early breast cancers frequently have no symptoms. The most frequent symptom among those with symptoms is a painless tumor. Only 5% of individuals with a malignant mass report breast pain, suggesting that pain or discomfort is not typically a symptom of breast cancer. Breast cancer is diagnosed based on a patient's medical history, physical examination, results of mammograms and/or ultrasounds, and pathologic evaluation of specimens. The sort of therapy given to a breast cancer patient depends on the stage of the disease after a diagnosis has been made. Depending on the preliminary stage, laboratory testing and imaging examinations are carried out.
Molecular breast cancer pathology:
a situs ductal carcinoma (DCIS):
There are two categories of in situ ductal carcinoma, which is a malignant growth of epithelial cells restricted to the duct lumen. Low grade solid, cribriform, and micropapillary group with uniform cells without area of necrosis and high grade comedocarcinoma formed of pleomorphic cells with central necrosis. Based on cytologic characteristics, clinging cancer was classified into one of two groups [4, 5, 21].
In situ carcinomas were recently separated into three grades, with comedocarcinoma being assigned to grade 3 [5]. Solid, cribriform, and micropapillary carcinomas were assigned to grade 1 if their cytologic morphology was bland, and they were categorized as grade 2 if their cytologic morphology was intermediate.
Thank you….
Welcome to the CME/CPD accredited 12th World Breast Pathology & Breast Cancer Conference on At December 15-17, 2023 in Dubai, UAE. We have scheduled the conference on Breast Cancer Awareness Month. What can be better than that to discuss Breast Cancer?
For more information and submission of your presentation or paper or abstract or poster, please check it on the website: https://breastcancerpathology.universeconferences.com/submit-abstract/
This event will be hosted virtually/online. Please register to get access to the entire program closer to the date. Register Now:https://breastcancerpathology.universeconferences.com/registration/
If you have any questions or doubts related to the abstract, registration, registration fee, or conference details, then definitely let us know.
ContactUs:-
Email us: breastcancer@ucgconferences.com
Visit Homepage: https://breastcancerpathology.universeconferences.com/
Call for Papers: https://breastcancerpathology.universeconferences.com/submit-abstract/
Register here: https://breastcancerpathology.universeconferences.com/registration/
Call Us/WhatsApp Us: +12076890407/+442033222718
You can see the Link: https://youtu.be/xdf1lD4-V_k
Previous Blog Post Links:-
https://medium.com/@elizaedwards2021/10th-world-breast-pathology-and-breast-cancer-conference-6db6e4fc81c2
https://sites.google.com/d/1GjMkcTpPR0amj-1dp877__PsqdODuGcv/p/16KaMjrLJn3LkYn4nRYLnRefvkHvCqL0M/edit
https://medium.com/@elizaedwards2021/breast-cancer-hysterectomy-and-removal-of-ovaries-and-tubes-954c834d8b0d
https://www.blogger.com/blog/post/edit/3238443600245550728/6484818089778744696
https://www.blogger.com/blog/post/edit/3238443600245550728/3714620114154946717
https://medium.com/@BreastPathology/importance-of-breast-pathology-33be3b0eed28
https://www.linkedin.com/pulse/meaning-definition-oncology-dr-priya-pujhari
https://drandreaross.blogspot.com/2022/10/assessment-of-mitosis-detection-in.html
https://medium.com/@BreastPathology/bone-and-soft-tissue-pathology-c56689328673
https://kikoxp.com/posts/16181
https://drandreaross.blogspot.com/2022/10/breast-surgery-impacts-on-patient-by-mr.html
https://kikoxp.com/posts/18551
Comments
Post a Comment